Results 51 to 60 of about 5,873,224 (308)

Style of Coping and its Determinants in Adults with Congenital Heart Disease in a Developing Country

open access: yes, 2014
Objective The objective of this study is to compare coping strategies between adults with and without congenital heart disease and to scrutinize the associations between different available resources (e.g., social support) and adoption of certain coping ...
Soares, Joaquim J. F.,   +6 more
core   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

Cell surface CD11c as a neutrophil aging marker molecule

open access: yesFEBS Open Bio, EarlyView.
Cell surface CD11chi neutrophils were more aged and had better phagocytic function than CD11c−/lo neutrophils. Transcriptomic analysis of CD11chi neutrophils and CD11c−/lo neutrophils in pediatric population showed that the most difference was seen in infants.
Sophia Koutsogiannaki   +5 more
wiley   +1 more source

Transcatheter Decellularized Tissue-Engineered Heart Valve (dTEHV) Grown on Polyglycolic Acid (PGA) Scaffold Coated with P4HB Shows Improved Functionality over 52 Weeks due to Polyether-Ether-Ketone (PEEK) Insert

open access: yesJournal of Functional Biomaterials, 2018
Many congenital heart defects and degenerative valve diseases require replacement of heart valves in children and young adults. Transcatheter xenografts degenerate over time.
Leon Bruder   +6 more
doaj   +1 more source

Pharmacological therapy in adult congenital heart disease with coronary artery disease and atrial fibrillation

open access: yesInternational Journal of Cardiology Congenital Heart Disease, 2023
Thanks to advances in both medical care and surgical techniques, over recent years, survival for patients with congenital heart disease (CHD) has increased significantly, with about 90% of patients now reaching adulthood.
Rosaria Barracano   +2 more
doaj   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

Coarctation of the Aorta: Diagnosis and Management

open access: yesDiagnostics, 2023
Coarctation of the aorta (CoA) accounts for approximately 5–8% of all congenital heart defects. Depending on the severity of the CoA and the presence of associated cardiac lesions, the clinical presentation and age vary.
Sadaf Raza   +10 more
doaj   +1 more source

Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients

open access: yes, 2009
Introduction. Glomerulopathy is a complication of congenital heart disease patients. The risk of developing renal impairment is particularly high in cyanotic patients. Objective. The aim of this study was to determine the prevalence of renal dysfunction
Fábregas-Brouard, Marian   +7 more
core   +1 more source

Multi-Institutional US Experience of the Occlutech© AFR Device in Congenital and Acquired Heart Disease

open access: yes, 2021
Objectives: To detail the US multi-institutional experience with the Occlutech© (Occlutech International AB, Helsingborg, Sweden) atrial flow regulator (AFR) in children and adults with acquired or congenital heart disease.
Anderson, Jason   +19 more
core   +1 more source

Non-cardiac surgery in congenital heart disease-associated pulmonary arterial hypertension: risk recognition and management [PDF]

open access: yes, 2020
Background Current guidelines for the peri-operative assessment and management are not sufficient to allow effective risk assessment and management of the patient with pulmonary arterial hypertension associated with congenital heart disease.
Constantine, Andrew, Clift, Paul
core   +1 more source

Home - About - Disclaimer - Privacy